US Bancorp’s iShares US Pharmaceuticals ETF IHE Stock Holding History

US Bancorp’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-162	Closed	-$14K	–	4258
2026 Q1	$14K	Hold	162	–	–	﹤0.01%	3243
2025 Q4	$13.7K	Hold	162	–	–	﹤0.01%	3223
2025 Q3	$11.8K	Sell	162 -222	-58%	-$15.3K	﹤0.01%	3262
2025 Q2	$25.2K	Hold	384	–	–	﹤0.01%	3088
2025 Q1	$27.1K	Hold	384	–	–	﹤0.01%	3041
2024 Q4	$25.2K	Hold	384	–	–	﹤0.01%	3066
2024 Q3	$27.1K	Buy	384 +222	+137%	+$15.5K	﹤0.01%	3019
2024 Q2	$10.7K	Sell	162 -480	-75%	-$31.5K	﹤0.01%	3284
2024 Q1	$43.6K	Buy	642 +264	+70%	+$17.5K	﹤0.01%	2772
2023 Q4	$23.4K	Buy	378 +201	+114%	+$11.8K	﹤0.01%	2981
2023 Q3	$10.4K	Buy	177 +15	+9%	+$920	﹤0.01%	3160
2023 Q2	$9.67K	Hold	162	–	–	﹤0.01%	3272
2023 Q1	$9.46K	Sell	162 -120	-43%	-$7.23K	﹤0.01%	3304
2022 Q4	$17.5K	Hold	282	–	–	﹤0.01%	3063
2022 Q3	$16K	Hold	282	–	–	﹤0.01%	3146
2022 Q2	$18K	Hold	282	–	–	﹤0.01%	3110
2022 Q1	$18K	Hold	282	–	–	﹤0.01%	3138
2021 Q4	$19K	Buy	282 +120	+74%	+$7.61K	﹤0.01%	3135
2021 Q3	$10K	Hold	162	–	–	﹤0.01%	3433
2021 Q2	$10K	Sell	162 -150	-48%	-$9.12K	﹤0.01%	3392
2021 Q1	$18K	Hold	312	–	–	﹤0.01%	3073
2020 Q4	$19K	Sell	312 -1,845	-86%	-$105K	﹤0.01%	2935
2020 Q3	$118K	Sell	2,157 -150	-7%	-$8.09K	﹤0.01%	2010
2020 Q2	$118K	Hold	2,307	–	–	﹤0.01%	2014
2020 Q1	$103K	Hold	2,307	–	–	﹤0.01%	2008
2019 Q4	$123K	Hold	2,307	–	–	﹤0.01%	2069
2019 Q3	$108K	Hold	2,307	–	–	﹤0.01%	2117
2019 Q2	$116K	Hold	2,307	–	–	﹤0.01%	2126
2019 Q1	$118K	Hold	2,307	–	–	﹤0.01%	2104
2018 Q4	$108K	Hold	2,307	–	–	﹤0.01%	2076
2018 Q3	$129K	Hold	2,307	–	–	﹤0.01%	2091
2018 Q2	$116K	Buy	2,307 +300	+15%	+$14.9K	﹤0.01%	2156
2018 Q1	$99K	Hold	2,007	–	–	﹤0.01%	2249
2017 Q4	$103K	Hold	2,007	–	–	﹤0.01%	2239
2017 Q3	$105K	Hold	2,007	–	–	﹤0.01%	2212
2017 Q2	$104K	Hold	2,007	–	–	﹤0.01%	2172
2017 Q1	$101K	Sell	2,007 -10,971	-85%	-$543K	﹤0.01%	2143
2016 Q4	$611K	Sell	12,978 -24	-0.2%	-$1.14K	﹤0.01%	1278
2016 Q3	$648K	Hold	13,002	–	–	﹤0.01%	1236
2016 Q2	$626K	Hold	13,002	–	–	﹤0.01%	1226
2016 Q1	$594K	Hold	13,002	–	–	﹤0.01%	1219
2015 Q4	$701K	Sell	13,002 -60	-0.5%	-$3.16K	﹤0.01%	1149
2015 Q3	$645K	Buy	13,062 +162	+1%	+$9.29K	﹤0.01%	1181
2015 Q2	$752K	Hold	12,900	–	–	﹤0.01%	1160
2015 Q1	$741K	Hold	12,900	–	–	﹤0.01%	1163
2014 Q4	$651K	Hold	12,900	–	–	﹤0.01%	1206
2014 Q3	$604K	Hold	12,900	–	–	﹤0.01%	1219
2014 Q2	$581K	Hold	12,900	–	–	﹤0.01%	1261
2014 Q1	$544K	Hold	12,900	–	–	﹤0.01%	1288
2013 Q4	$508K	Hold	12,900	–	–	﹤0.01%	1295
2013 Q3	$457K	Hold	12,900	–	–	﹤0.01%	1293
2013 Q2	$429K	Buy	+12,900	New	+$429K	﹤0.01%	1253

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

US Bancorp's IHE Position: Q2 2026 in Review

US Bancorp sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2026, closing a stake of 162 shares — an estimated $14K sold.

US Bancorp first reported a position in IHE in Q2 2013 and held it in 52 quarters. The position peaked at $752K in Q2 2015. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

US Bancorp reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
US Bancorp sold 162 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $14K.
US Bancorp first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 52 quarters.
US Bancorp's iShares US Pharmaceuticals ETF position peaked at $752K in Q2 2015.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.